ERYtech Pharma Revenue and Competitors
Estimated Revenue & Valuation
- ERYtech Pharma's estimated annual revenue is currently $4.1M per year.
- ERYtech Pharma's estimated revenue per employee is $14,130
- ERYtech Pharma's current valuation is $71.8M. (January 2022)
Employee Data
- ERYtech Pharma has 293 Employees.
- ERYtech Pharma grew their employee count by 1% last year.
ERYtech Pharma's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Directeur Général Délégué / Chief Financial Officer & Chief Operating Officer | Reveal Email/Phone |
3 | VP, Legal Affairs & General Counsel | Reveal Email/Phone |
4 | Head pharmaceutical and CMC regulatory affairs | Reveal Email/Phone |
5 | Director Pharmaceutical Operations and Qualified Person | Reveal Email/Phone |
6 | Chief Financial Officer & Chief Operating Officer | Reveal Email/Phone |
7 | Director Research and Development Operations | Reveal Email/Phone |
8 | HUMAN RESOURCES DIRECTOR | Reveal Email/Phone |
9 | Manufacturing Manager | Reveal Email/Phone |
10 | Safety Manager | Reveal Email/Phone |
ERYtech Pharma Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is ERYtech Pharma?
Founded in 2004, ERYtech Pharma is a biotechnology company specialized in the encapsulation of therapeutic molecules or enzymes into red blood cells. The company targets the development of products indicated in the treatment of serious types of cancer, such as solid or haematological tumours, for which existing treatments are particularly constraining. ERYtech Pharma significantly improves the therapeutic index of the encapsulated molecules or enzymes and thus patients' life conditions. Since its creation, ERYtech Pharma has received support from several national institutions.
keywords:N/A
N/A
Total Funding
293
Number of Employees
$4.1M
Revenue (est)
1%
Employee Growth %
$71.8M
Valuation
N/A
Accelerator
ERYtech Pharma News
Zero analysts have provided estimates for ERYTECH Pharma's earnings. The firm is scheduled to report its next quarterly earnings results on...
Cambridge, MA (U.S.) and Lyon (France), April 06, 2022 ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical...
ERYTECH is a clinical-stage biopharmaceutical company developing innovative red blood cell-based therapeutics for severe forms of cancer and...
ERYTECH Announces Upcoming Poster Presentation at the 2021 American Society of Hematology Annual Meeting Cambridge, MA (U.S.) and Lyon (France), November 15, 2021 – ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulat ...
ERYTECH Announces Publication of a Paper on Red-Blood Cell Characterization in High Impact Peer Reviewed Journal The Paper "Multiparametric characterization of red blood cell physiology after hypotonic dialysis based drug encapsulation process" is available in the October 2021 (Volume 11, Issue ...
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | N/A | 296 | 44% | N/A |
#2 | $59.2M | 299 | N/A | N/A |
#3 | $235M | 300 | -5% | $340.9M |
#4 | $79M | 305 | 70% | $81M |
#5 | $104.8M | 305 | 26% | N/A |